(Q37963474)

English

Translational Mini-Review Series on B cell subsets in disease. Transitional B cells in systemic lupus erythematosus and Sjögren's syndrome: clinical implications and effects of B cell-targeted therapies

scientific article published on January 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 August 2017

Translational Mini-Review Series on B cell subsets in disease. Transitional B cells in systemic lupus erythematosus and Sjögren's syndrome: clinical implications and effects of B cell-targeted therapies (English)

1 reference

Europe PubMed Central

26 August 2017

Sjögren's syndrome

1 reference

based on heuristic

inferred from title

lupus erythematosus

1 reference

based on heuristic

inferred from title

systemic lupus erythematosus

1 reference

based on heuristic

inferred from title

author name string

A Vossenkämper

1

1 reference

Europe PubMed Central

26 August 2017

P M K Lutalo

2

1 reference

Europe PubMed Central

26 August 2017

J Spencer

3

1 reference

Europe PubMed Central

26 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2012

1 reference

Europe PubMed Central

26 August 2017

Clinical and Experimental Immunology

1 reference

Europe PubMed Central

26 August 2017

167

1 reference

Europe PubMed Central

26 August 2017

1

1 reference

Europe PubMed Central

26 August 2017

7-14

1 reference

Europe PubMed Central

26 August 2017

Translational Mini-Review Series on B cell subsets in disease. Reconstitution after haematopoietic stem cell transplantation - revelation of B cell developmental pathways and lineage phenotypes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Treatment of systemic lupus erythematosus with epratuzumab.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

CD22 regulates adaptive and innate immune responses of B cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

SWAP-70 controls formation of the splenic marginal zone through regulating T1B-cell differentiation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Epratuzumab targeting of CD22 affects adhesion molecule expression and migration of B-cells in systemic lupus erythematosus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double-blind, placebo-controlled, dose-ranging study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Differential expression of CD21 identifies developmentally and functionally distinct subsets of human transitional B cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Baseline autoantibody profiles predict normalization of complement and anti-dsDNA autoantibody levels following rituximab treatment in systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Rituximab in systemic lupus erythematosus: A systematic review of off-label use in 188 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Human marginal zone B cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Ectopic germinal centers are rare in Sjogren's syndrome salivary glands and do not exclude autoreactive B cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Effects of rituximab on resistant SLE disease including lung involvement.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Lambda light chain revision in the human intestinal IgA response.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and APRIL.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Reduction of fatigue in Sjögren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Cutting edge: Transitional T3 B cells do not give rise to mature B cells, have undergone selection, and are reduced in murine lupus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

B cell depletion therapy in systemic lupus erythematosus: long-term follow-up and predictors of response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Identification of anergic B cells within a wild-type repertoire.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

The BLyS/BAFF family of ligands and receptors: key targets in the therapy and understanding of autoimmunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase I/II study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Identification of transitional type II B cells in the salivary glands of patients with Sjögren's syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Similarities and differences between selective and nonselective BAFF blockade in murine SLE

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

B-cell tolerance checkpoints in healthy humans and patients with systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Expansion of functionally immature transitional B cells is associated with human-immunodeficient states characterized by impaired humoral immunity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Repeated B cell depletion in treatment of refractory systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Characterization of marginal zone B cell precursors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Basal immunoglobulin signaling actively maintains developmental stage in immature B cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Defective B cell tolerance checkpoints in systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Identification and characterization of circulating human transitional B cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Predominant autoantibody production by early human B cell precursors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Transitional B cells: step by step towards immune competence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

BAFF AND APRIL: a tutorial on B cell survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjögren's syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Immune cell signaling in lupus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

CD19 and CD22 expression reciprocally regulates tyrosine phosphorylation of Vav protein during B lymphocyte signaling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Receptor editing: an approach by autoreactive B cells to escape tolerance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Memory B cells in T cell-dependent antibody responses colonize the splenic marginal zones.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Clonal deletion of autoreactive B lymphocytes in bone marrow chimeras

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3248081

16 September 2018

Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04460.X

21 January 2018

Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04460.X

21 January 2018

Treatment of refractory SLE with rituximab plus cyclophosphamide: clinical effects, serological changes, and predictors of response

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04460.X

21 January 2018

A multicenter phase I/II trial of rituximab for refractory systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04460.X

21 January 2018

Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04460.X

21 January 2018

Treatment of primary Sjogren syndrome with rituximab: extended follow-up, safety and efficacy of retreatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/22132879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characteristics of the minor salivary gland infiltrates in Sjögren's syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/22132879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Three different B-cell depletion (anti-CD20 monoclonal antibodies) treatments for severe resistant systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/22132879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab

1 reference

https://pubmed.ncbi.nlm.nih.gov/22132879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of early plasma cells in peripheral blood and their clinical significance

1 reference

https://pubmed.ncbi.nlm.nih.gov/22132879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/22132879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BAFF overexpression is associated with autoantibody production in autoimmune diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/22132879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BAFF-induced changes in B cell antigen receptor-containing lipid rafts in Sjögren's syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/22132879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Naive recirculating B cells mature simultaneously in the spleen and bone marrow

1 reference

https://pubmed.ncbi.nlm.nih.gov/22132879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Will targeting B cells be the answer for Sjögren's syndrome?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22132879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/22132879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of immunoglobulin light chain gene rearrangements during early B cell development in the human

1 reference

https://pubmed.ncbi.nlm.nih.gov/22132879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Competition for BLyS-mediated signaling through Bcmd/BR3 regulates peripheral B lymphocyte numbers

1 reference

https://pubmed.ncbi.nlm.nih.gov/22132879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjögren's syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/22132879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22132879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential effects of epratuzumab on peripheral blood B cells of patients with systemic lupus erythematosus versus normal controls

1 reference

https://pubmed.ncbi.nlm.nih.gov/22132879

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2249.2011.04460.X

1 reference

Europe PubMed Central

26 August 2017

0 references

1 reference

Europe PubMed Central

26 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37963474&oldid=2161113646"